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Pseudomonas aeruginosa is an important pathogen in opportunistic infections in
humans. The increased incidence of antimicrobial-resistant P. aeruginosa isolates has
highlighted the need for novel and more potent therapies against this microorganism.
Annona glabra is known for presenting different compounds with diverse biological
activities, such as anti-tumor and immunomodulatory activities. Although other species
of the family display antimicrobial actions, this has not yet been reported for A. glabra.
Here, we investigated the antimicrobial activity of the ethyl acetate fraction (EAF)
obtained from the leaf hydroalcoholic extract of A. glabra. EAF was bactericidal
against different strains of P. aeruginosa. EAF also presented with a time- and
concentration-dependent effect on P. aeruginosa viability. Testing of different EAF sub-
fractions showed that the sub-fraction 32-33 (SF32-33) was the most effective against
P. aeruginosa. Analysis of the chemical constituents of SF32-33 demonstrated a high
content of flavonoids. Incubation of this active sub-fraction with P. aeruginosa ATCC
27983 triggered an endothermic reaction, which was accompanied by an increased
electric charge, suggesting a high binding of SF32-33 compounds to bacterial cell
walls. Collectively, our results suggest that A. glabra-derived compounds, especially
flavonoids, may be useful for treating infections caused by P. aeruginosa.
Keywords: Annona glabra, Pseudomonas aeruginosa, antimicrobial activity, flavonoids
INTRODUCTION
Infection by Pseudomonas aeruginosa, a Gram-negative bacterium known to cause a variety of
opportunistic infections in humans, can result in pneumonia, sepsis, meningitis, and urinary tract
infections, as well as skin and soft-tissue infections (Wroblewska, 2006). The increasing prevalence
of P. aeruginosa isolates that are resistant to almost all antimicrobials has raised concern among
public health authorities in recent decades and highlights the importance of developing novel
antimicrobial drugs active against this pathogen (Porras-Gomez et al., 2012). The development
of resistance in P. aeruginosa is considered multifactorial, with mutations in several genes that
encode eﬄux pumps, porins, penicillin-binding proteins, and chromosomal β-lactamases (Poole,
2011; Morita et al., 2014). All of these genes are involved in the resistance to distinct antibiotic
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classes, including penicillins, carbapenems, aminoglycosides, and
fluoroquinolones (Ozer et al., 2009).
Natural compounds have been extensively studied as
potential sources of antimicrobial compounds. Indeed, different
natural compounds were suggested as antimicrobials against
P. aeruginosa (Hayashi et al., 2014; Yang et al., 2015; Undabarrena
et al., 2016); with some of them acting as eﬄux pump inhibitors
in P. aeruginosa, thus contributing to reversal of resistance in
these strains (Morita et al., 2016).
Annona glabra Linn is a tropical fruit tree native to Florida
(United States of America), the Caribbean, and Central and South
Americas. It has a wide distribution in Brazil, mainly in mangrove
areas (Núñez-Elisea et al., 1999). Annona glabra is a potential
source of compounds for cancer therapy, where an alcoholic seed
extract has shown anticancer activity (Cochrane et al., 2008). In
addition, a preliminary screening also demonstrated substantial
antimicrobial activities for the hexane extract of A. glabra stem
bark (Padmaja et al., 1995).
Antimicrobial activity was recently reported in other Annona
species. The hexane and chloroform fractions obtained from
Annona vepretorum leaves display antimicrobial activity against
Escherichia coli, Klebsiella pneumoniae, and Staphylococcus
aureus (Almeida et al., 2014). Additionally, Rinaldi and
collaborators showed that the methanol, dichloromethane, and
ethyl acetate fractions (EAFs) obtained from Annona hypoglauca
stems inhibited the growth of Staphylococcus aureus and
Enterococcus faecalis (Rinaldi et al., 2016).
Different compounds may confer antimicrobial properties for
plants, with flavonoids being one of the major compounds to
which these effects have been attributed. To date, compounds,
such as annoglabayin and methyl-16 alpha-hydro-19-al-ent-
kauran-17-oate (kaurane diterpenoids; Chen et al., 2004; Zhang
et al., 2004) and squamosamides (Bao et al., 2015), have been
identified and isolated from A. glabra fruits. However, little is
known regarding the flavonoid content in this plant or their
ability to function as antimicrobials.
Herein, we evaluated the antibacterial effects of the
hydroalcoholic extract from A. glabra leaves against standard
and clinical isolates of P. aeruginosa and characterized the
antibacterial effects of the EAF. Additionally, the interactions
between a flavonoid-rich sub-fraction (SF) of EAF (SF32-33) and
P. aeruginosa was investigated by characterization of changes in
the zeta potential (ZP) and enthalpy.
MATERIALS AND METHODS
Plant
The stems, leaves, and fruits of Annona glabra Linn (Arecaceae)
were collected at “Central do Maranhão,” Maranhão, Brazil
(2◦16′20.2′′ S, 44◦ 57′14.2′′ W). A voucher specimen (N◦ 01077)
was deposited in the herbarium Ático Seabra of the Federal
University of Maranhão, São Luís, Brazil.
Preparation of Extracts from Leaves
Collected leaves were washed in running water for up to
5 min before being dried at room temperature. The dried
leaves were triturated using a blender (Siemsen, model LI-1.5,
São Paulo, Brazil) for 20 min to obtain a fine powder, and
300 g were extracted twice with 1000 ml ethyl alcohol (99.5%;
Sigma–Aldrich, St. Louis, MO, USA) at room temperature, with
a 5 days period between extractions. The mixture was filtered
through cellulose filter paper (Whatman No. 4, GE Healthcare
UK, Amersham, UK) and evaporated to dryness under reduced
pressure using a rotary evaporator (Eyela N-1200BV-W, Tokyo,
Japan) at 40◦C. The residual solvent was removed in a vacuum
centrifuge at 40◦C to yield crude ethanol extracts of leaves.
Preparation of the EAF from the Leaf
Hydroalcoholic Extract of A. glabra
The EAF was obtained from the leaf hydroalcoholic extract
of A. glabra as previously described (de Siqueira et al., 2014).
For this, six grams of the ethanol extract were suspended
in MeOH:H2O (4:1) using an ultrasonic bath (Elmasonic R©
E 30H Elma, Sigen, Germany) and extracted successively
by solvent-solvent partitioning. For concentration and mass
determination, 10 ml of EAF was dried in a Speedvac system
(Speed Vac Concentrator Sc110, Savant, Thermo Fisher Scientific
Inc., Waltham, MA, USA) at 50◦C for 60 h. For in vitro
assays, EAF and SF stock solutions were prepared in dimethyl
sulfoxide (DMSO; Sigma–Aldrich, St. Louis, MO, USA) at
50 mg/ml.
Procedure for Gel Permeation
Chromatography (GPC)
Ethyl acetate fraction SFs were obtained by GPC. For this,
3.15 g/ml of EAF was injected into GPC glass columns
(Büchi column n◦ 17980), packaged with Sephadex LH-20
TM gel (GE Healthcare, USA), and eluted in 2 ml of 99%
methanol (P.A., Merck, Darmstadt, Germany). For the mobile
phase, the eluate was pumped at a flow rate of 480 ml/h,
for 4 h and two hundred fractions were then collected
(20 ml/tube).
Thin Layer Chromatography (TLC)
Analysis
Ethyl acetate fraction SFs were characterized by TLC analysis
on pre-coated commercial silica gel plates G-60/F254 (0.25 mm,
Merck, Darmstadt, Germany). Briefly, TLC plates were eluted
using solvent mixtures in different proportions: (i) ethyl
acetate:methanol:water (EtOAc:MeOH:H2O/80:11:5 v/v)
for polar compounds or (ii) dichloromethane:methanol
(DCM:MeOH/95:5 v/v) for non-polar compounds. High content
flavonoid blottings were visualized under UV light at 360 nm
after spraying the plates with a mixture (1:1) of an ethanol
solution containing vanillin 1% w/v and sulfuric acid at 10%
(v/v) or 2-aminoethyl diphenylborinate/polyethylene glycol 4000
(NP/PEG) solution in ethanol at 2% (w/v; de Siqueira et al.,
2014). Sub-fractions with similar blotting profiles were pooled
and analyzed in microbiological assays [Minimum inhibitory
concentrations (MIC) and Minimum bactericidal concentrations
(MBC)].
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Liquid Chromatography-High Resolution
Mass Spectrometry (LC-HRMS) Analysis
The LC-HRMS (MSMS) analysis of the flavonoid-rich SF SF32-
33 was performed on a Nexera UHPLC system (Shimadzu
Corporation, Kyoto, Japan) hyphenated to a maXis ETD high
resolution ESI-QTOF (ElectroSpray Ionization – Quadrupole
Time of Flight) mass spectrometer (Bruker Daltonics, Bremen,
Germany) and controlled by the Compass 1.5 software package
(Bruker Daltonics, Bremen, Germany), according to a previously
described method (de Siqueira et al., 2014). For analysis, SF32-
33 (10 µg/ml) was dissolved in ACN:H2O (1:1 v/v) and injected
into a Shimadzu Shim-Pack XR-ODS-III column (C18, 2.2 µm,
80 Å, 2.0 mm × 200 mm) at a flow rate of 200 µL/min. SF32-33
was then sequentially eluted with mixtures of water containing
0.1% formic acid (Solution A), followed by acetonitrile solution
containing 0.1% formic acid (Solution B). For the application of
Solution B, 10% was applied over a 10-min period, followed by
a linear gradient (10–100%) for 40 min, and finally 100% for
5 min. Ion-source parameters were set to 500 V for end plate
offset, 4500 V for capillary voltage, 2.0 bar nebulizer pressure,
and 8.0 l/min dry gas flow at 200◦C. Data-dependent precursor
fragmentation was performed at collision energies of 30 eV.
Ion cooler settings were optimized for an average sensitivity of
40–1000 m/z range using a solution of 10 mM sodium formate in
2-propanol/0.2% formic acid (1:1, v/v) as the calibration solution.
Mass calibration was achieved by initial ion-source infusion
of 20 µl calibration solution and post-acquisition recalibration
of the raw data. Compound identification was performed
by chromatographic peak dissection, with subsequent formula
determination according to exact mass and isotope pattern (MS1)
and database comparison of compound fragment spectra (MS2),
as well as the comparison of compound fragment spectra and
co-elution with standard compounds (Sigma–Aldrich, St. Louis,
MO, USA). Sources of reference ESI fragmentation pattern
spectra consisted of an in-house database of commercial or
isolated and identified compounds, as well as the public spectra
database MassBank (Horai et al., 2010).
Antimicrobial Activity Assays
Antibacterial activity assays were evaluated using the following
microorganisms: P. aeruginosa ATCC 27983 (kindly donated by
the Instituto Nacional de Controle de Qualidade em Saúde –
da Função Instituto Osvaldo Cruz, INCQS–FIOCRUZ, Rio de
Janeiro, Brazil) and 10 multi-resistant P. aeruginosa clinical
strains from the culture collection of the laboratory (Table 1, first
column). Minimum inhibitory concentrations were determined
using the broth microdilution method, as described in CLSI M07-
A10 (CLSI, 2015), with minor modifications. For this, different
concentrations of EAF or SF32-33 (0.05–1024 µg/ml) were
incubated with 100 µl of Mueller–Hinton broth (MHB, Difco,
Detroit, MI, USA) in 96-well plates. Vehicle (1% DMSO)-treated
wells were used as negative controls. Then, a bacterial inoculum
(5 × 105 CFU/mL) was added into the wells. Sterility controls
were included for each assay, and tests were performed on
three occasions in triplicate. Ciprofloxacin-treated wells (Sigma–
Aldrich, St. Louis, MO, USA) were used as positive controls
(0.05–1024 µg/ml). The microdilution plates were incubated
under aerobic conditions at 35◦C for 24 h. The MIC was defined
as the lowest concentration of EAF or SF32-33 that completely
inhibited the visible growth of microorganisms.
Minimum bactericidal concentrations were evaluated soon
after determining the MIC. For this, 100 µl of culture medium
was removed from each well with no visible growth and
transferred to Mueller–Hinton agar plates. Plates were then
incubated at 35◦C for 24 h. The MBC was considered as the
lowest concentration that either totally prevented growth or
resulted in a ≥99.9% decrease in the initial inoculum (i.e., a
3 log10 reduction in CFU/ml) upon subculture. Bacteriostatic
action was defined as a ratio of MBC to MIC that is >4.
Otherwise, a lower MBC to MIC ratio was defined as bactericidal
action (Pankey and Sabath, 2004). All tests were performed in
triplicate.
Time-Kill Assays
The time-dependent effects of SF32-33 on P. aeruginosa viability
were evaluated by measuring the reduction in the numbers of
CFU per milliliter for 3–24 h. Briefly, SF32-33 (2.0–64 µg/ml)
was added to each well and incubated with 104 CFU/ml of
P. aeruginosa ATCC 27983 for 3–24 h at 35◦C. A 100-µl aliquot
of bacterial inoculum was removed from the microtiter plates
containing SF32-33 at different intervals until 24 h, and were
serially diluted in sterile saline, before plating onto MacConkey
agar (BBLTM MacConkey Agar, BD, Sparks, MD, USA) plates for
colony count determinations. The plates were incubated at 35◦C
for 24 h prior to colony counting. The results were expressed as
the percentage of P. aeruginosa in relation to the negative control
wells (vehicle-treated) for each time analyzed. The data represent
the mean values of three independent experiments in duplicate
assays. Vehicle-treated wells were used as controls.
TABLE 1 | Antimicrobial activity of the leaf hydroalcoholic extract and the
ethyl acetate fraction (EAF) of Annona glabra on Pseudomonas
aeruginosa strains.
Bacterial strains Concentration (µg/ml)
Hydroalcoholic extract EAF
MIC MBC MIC MBC
ATCC 27853 1024 2048 8 16
P1C 1024 2048 8 16
P2C 1024 2048 8 16
P5C 1024 2048 8 16
P18C 1024 2048 8 16
P27C 1024 2048 8 16
P32C 1024 2048 4 4
P110c 1024 2048 8 16
P113C 1024 2048 8 16
P146C 1024 1024 4 8
P165C 1024 2048 8 16
Minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations
(MBC) were calculated and expressed in µg/ml. Assays were performed in
duplicate on three different experiments.
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Effect of Flavonoids on Zeta Potential of
Bacterial Cell Surfaces
To evaluate whether the SF32-33 interacts with the P. aeruginosa
cell walls, P. aeruginosa ATCC 27983 was grown in Tryptic
Soy Broth (BactoTM Tryptic Soy Broth, TSB, BD, Sparks, MD,
USA) for 18 h at 35◦C, as previously described (Soon et al.,
2011). Cells were then washed three times with sterile phosphate
buffered saline (PBS, pH = 7.2) and centrifuged at 5,000 × g for
10 min at 4◦C. The supernatant was discarded, and the cells were
resuspended in 10 ml of KCl solution (10 mM) and vortexed for
1 min.
The ZP was measured to determine the ability of SF32-33
to modify the electrical charge of the P. aeruginosa cell walls.
ZP measurements were conducted at 25◦C using a 64-channel
Zetasizer Nano ZS system (Malvern) at 633 nm (red Leisure)
and Malvern Laser Doppler Velocimetry patterns coupled with
M3-PALS (Phase Analysis Light Scattering). Briefly, 3 ml of a
P. aeruginosa cell suspension containing 1 × 108 CFU/ml was
incubated with 10 µl of a SF32-33 stock solution of 23 µg/ml
into a 25 ml glass container. Then, 1 ml of the mixture was
transferred into a plastic cuvette (Cell-Folded Capillary DTS1060;
Malvern). Titration (0–1.5 µg/ml) was performed 20 times by
manual injection of 10 µl of the mixture. For each titration,
the solution was transferred to the same cuvette, and the liquid
charge was recorded in millivolts (mV), which was considered as
the ZP. Each titration was repeated 10 times, and the results were
expressed as the average of ten repetitions for each titration.
Isothermal Titration Calorimetry Assays
Isothermal titration calorimetry (ITC) assays were performed
to determine the thermodynamic parameters of interaction
between the SF32-33 and P. aeruginosa ATCC 27853 cells
in suspension. The experiments were performed in duplicate
using a VP-ITC microcalorimeter at 25◦C (MicroCal Company,
Northampton, MA, USA). The titration consisted of 50 5-µL
successive automated injections (at intervals of 300 s each)
of an SF32-33 stock solution (23 µg/ml) into a cuvette
containing 1.5 ml of P. aeruginosa suspension (1× 108 CFU/ml).
The SF32-33 concentrations ranged from 0 to 3.28 µg/ml.
Corrections of concentrations, as well as the integration
of the heat flow peaks involved in specific enthalpies of
interaction (1injH◦ in kcal/µg of SF32-33), were made using
MicroCal Origin 7.0 software for ITC (Microcal, Northampton,
MA, USA). Injections of SF32-33 into a cuvette charged
with 1.5 ml of solvent only were used as the control
in order to determine possible release of energy during
titration. All solutions were prepared in 0.9% saline in Milli-
Q purified water (pH = 7.0). The results were expressed as the
difference of enthalpy between the solvent and SF32-33 itself
(1injH◦).
Statistical Analysis
The data obtained in the time-kill and cytotoxicity assays were
analyzed with GraphPad Prism (version 5.0; GraphPad Software,
Inc. San Diego, CA, USA) using the Mann–Whitney non-
parametric tests with a confidence interval of 95%. Differences
between treated and control groups were considered significant
for any p-value< 0.05.
RESULTS
Characterization of the Antimicrobial
Effects of the Leaf Hydroalcoholic
Extract and EAF of A. glabra
Qualitative analysis of the hydroalcoholic extract of A. glabra
showed a high content of flavonoids. A similar profile was
found for the EAF when it was analyzed by TLC, especially
for the SF32-33 fraction. Evaluation of the antimicrobial
effects of A. glabra showed a MIC of 1024 µg/ml for the
hydroalcoholic extract when tested against the P. aeruginosa
clinical isolates and ATCC 27853 (Table 1). An MBC of
2048 µg/ml was observed for all the tested bacteria, except
for one of the clinical isolates (P146c) in which the MBC
was 1024 µg/ml (Table 1). EAF was highly effective against
P. aeruginosa, presenting an MIC of 4–8 µg/ml and an
MBC of 8–16 µg/ml (Table 1). MIC evaluation for different
SFs showed that SF32-33 (4 µg/ml) was the most effective
against P. aeruginosa, followed by SF18-19, which presented
an MIC of 64 µg/ml (Table 2). All the other SFs tested
exhibited MICs ranging from 256 to 512 µg/ml (Table 2).
LC-HRMS analysis confirmed that SF32-33 is a flavonoid-rich
SF containing (-) epicatechin, fisetin, quercetin, rutin, hyperosid,
isoquercitrin, quercitrin, kaempferol 7-neohesperidoside,
nicotiflorine, and naringenin (Table 3). Ciprofloxacin, a
commercially available antimicrobial, exhibited an MIC
and MBC of 32 and 64 µg/ml, respectively, for the multi-
resistant clinical strain of P. aeruginosa P2C. Therefore, both
SF32-33 and ciprofloxacin were able to significantly reduce
P. aeruginosa growth, with reductions of 5.92 and 5.87 log
CFU/ml, respectively.
TABLE 2 | Antimicrobial activity of different ethyl acetate fraction (EAF)
sub-fractions (SF) of A. glabra on P. aeruginosa strains.
Sub-fractions Concentration (µg/ml)
ATCC 27853 P2C
SF 1-15 512 512
SF 16-17 512 512
SF 18-19 64 64
SF 20-22 512 512
SF 23-24 512 512
SF 25-26 512 512
SF 27-28 512 512
SF 29-31 512 512
SF 32-33 4 4
SF 34-36 512 512
SF 37-40 256 256
SF R 512 512
Minimum inhibitory concentrations were calculated and expressed in µg/ml.
Assays were performed in duplicate on three different experiments.
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TABLE 3 | Liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis of SF32-33.
Compound Rt/min m/z [M+H]+ Formula Fragment ions
(abundance)
Identification method Fit score
(purity)
(-) Epicatechin 9.4 291.0867 C15 H14O6 291.0867 (100)
291.1497 (2.5)
Standard/in-house DB 990
Rutin 14.7 305.0661,
611.1612
C15 H12O7
C27H31O16
153.0183 (100)
185.0605 (37.8)
201.0571 (19.9)
Standard/in-house DB 999
Hyperoside 14.9 465.1037 C21 H20 O12 303.0502 (100)
303.1152 (2.3)
303.4847 (1.8)
Standard/in-house DB 999
Quercetin 15.7 303.0503,
435.0929
C15H10O7
C20H18O11
303.0501 (100)
303.1152 (2.7)
303.4851 (1.9)
Standard/in-house DB 990
Fisetin 16.3 287.0554 C15H10O6 287.0547 (100)
288.0580 (13.1)
289.0602 (2.1)
Standard/in-house DB 928
Quercitrin 17.0 303.0502,
449.108
C15H10O7
C21 H20O11
303.0500 (100)
304.0533 (15.8)
305.0558 (2.6)
449.1082 (12.8)
Standard/in-house DB 931
Kaempferol-7-neohesperidoside nicotiflorine 19.0 595.1460 C27H30O15 595.1460 (100)
596.1505 (63.3)
597.1533 (22.4)
625.1564 (25.3)
Standard/in-house DB 820
Naringenin 19.9 773.1933,
273.0762
C15H12O5 773.1933 (100)
773.2955 (2.8)
774.1968 (37.6)
153.0184 (100)
154.0218 (6.3)
Standard/in-house DB 990
Time-Kill Assays
To evaluate whether the effect of SF32-33 on P. aeruginosa
was time- and/or dose-dependent, we performed a time-kill
assay. Figure 1 shows that SF32-33 presented a dose- and time-
dependent effect on P. aeruginosa ATCC 27853 where growth
inhibition was maximal at 24 h post-incubation (96% inhibition;
p< 0.005).
Effect of SF32-33 toward the Zeta
Potential of P. aeruginosa
Zeta potential measurements were performed in order to
investigate the ability of SF32-33 to interact with the cell wall
surface of P. aeruginosa ATCC 27853. The results showed that
by incubating P. aeruginosa with cumulative concentrations of
SF32-33 (up to 1.5 µg/ml), there was a shift in the ZP from a
negative to positive charge (−8.21 to+2.95 mV; Figure 2).
Isothermal Titration Calorimetry Assays
Isothermal titration calorimetry assays were performed in order
to analyze the thermal profile of the interaction between SF32-33
and P. aeruginosa ATCC 27853. The data depicted in Figure 3
demonstrate that the incubation of cumulative concentrations
of SF32-33 (0–3.28 µg/ml) with P. aeruginosa resulted in an
endothermic reaction, as indicated by the graph of molar
enthalpy of titrant – 1injH◦ (in kcal/µg of titrant), against
distinct concentrations of SF32-33 in µg/ml. Furthermore, the
observed parabolic profile obtained suggests that the interaction
between SF32-33 and P. aeruginosa may occur through different
mechanisms.
DISCUSSION
Although antimicrobial activities were previously reported for
other Annona species, little is known on A. glabra ability to inhibit
bacterial growth and/or viabilty. To the best of our knowledge
we present the first evidence on that the EAF obtained from
the leaf hydroalcoholic extract of A. glabra presents a potent
antimicrobial activity against P. aeruginosa. We found that this
activity is especially related to SF32-33, a flavonoid-rich SF of
EAF. The antimicrobial actions of SF32-33 are due to its ability
to interact with the bacterial cell wall surface, resulting in an
endothermic reaction. These results suggest the existence of a
strong binding event between SF32-33 and P. aeruginosa.
Analysis of the MIC and MBC of the hydroalcoholic extract,
EAF, and SF32-33 demonstrated that the hydroalcoholic extract
was not as effective as the EAF and SF32-33 in inhibiting bacterial
growth and survival. By comparison, SF32-33 was the most
effective against P. aeruginosa, presenting the lowest MIC and
MBC. The effect of SF32-33 on P. aeruginosa viability was further
investigated in a time-kill assay. SF32-33 had a dose- and time-
dependent effect on P. aeruginosa ATCC 27853. Indeed, these
effects were observed as soon as 6 h post-incubation of SF32-
33 and lasted for 24 h. Although antibacterial activity has been
attributed to fractions obtained from other plants of the Annona
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FIGURE 1 | Time-dependent effect of SF32-33 on Pseudomonas aeruginosa ATCC 27853 survival. (A) Percentage of P. aeruginosa viability in relation to the
negative control wells (vehicle-treated) at different time points (3–24 h). (B) Representative panels of P. aeruginosa growth in CFU/ml following incubation with
SF32-33 for 12 h. Assays were performed three times in duplicate. The limit of detection in the assay was of 103 CFU/ml. ∗p < 0.05; differs from the vehicle-control.
FIGURE 2 | Effect of flavonoids on the zeta potential (ZP) of P. aeruginosa ATCC 27983. ZP was measured in 10 mM KCl expressed in mV as a function of
SF32-33 concentration. Each point represents an average of 10 repetitions for each titration.
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FIGURE 3 | Isothermal titration calorimetry (ITC) result of the
interaction thermodynamics between SF32-33 and P. aeruginosa
ATCC 27853. The titration consisted of 50 5-µL successive automated
injections (at intervals of 300 s each) of SF32-33 stock solution (23 µg/ml) into
a cuvette containing 1.5 ml of P. aeruginosa suspension (1 × 108 CFU/ml).
The results are expressed as the difference of enthalpy between the solvent
and SF32-33 itself (1injH◦ in kcal/µg).
genus (A. vepretorum and A. hypoglauca), their MIC and MBC
were much higher (≤100 mg/ml; Almeida et al., 2014; Rinaldi
et al., 2016) in comparison to those observed for the EAF of
A. glabra in our study (≤16 µg/ml).
The TLC and LC-HRMS results indicated that SF32-
33 is rich in flavonoids. Whilst the other fractions of the
extract (methanol, hexane, and dichloromethane) displayed low
content of flavonoids (data not shown), partitioning of the
extract with ethyl acetate allowed a greater enrichment in
flavonoids. The antibacterial effects of flavonoids have been
widely reported in the literature. Indeed, these effects have
been attributed to their chemical structure, considering the
number and positions of methoxyl and hydroxyl groups in
the core C3 (Wu et al., 2013), which confer an intrinsic
electrical charge and high hydrophobicity to these compounds.
These characteristics favor increased membrane fluidity in the
bacterial cell (Tsuchiya and Iinuma, 2000; Wu et al., 2013).
In a recent study using a structure-activity relationship model,
flavonoids were shown to affect Escherichia coli viability by
damaging its outer membrane (Fang et al., 2016). Considering
the high hydrophobicity of both flavonoids and the P. aeruginosa
cell wall, it is possible that SF32-33 has an effect on
P. aeruginosa viability and growth due to a strong hydrophobic
interaction.
By performing an LC-HRMS analysis, it was possible to
identify different flavonoids in the SF32-33, including (-)-
epicatechin, fisetin, quercetin, rutin (quercetin glycoside),
hyperosid, isoquercitrin, quercitrin, kaempferol 7-
neohesperidoside, nicotiflorine, and naringenin. To our
knowledge, we present the first evidence of the compounds
found in the EAF of A. glabra. Many of them have already
been shown to present antimicrobial actions against different
bacteria, but little is known of their ability to inhibit P. aeruginosa
growth/viability.
The structure of (-) epicatechin is composed of two aromatic
rings linked by an oxygen heterocycle with a 4-hydroxyl
group (Fraga and Oteiza, 2011). Epicatechins are flavan-3-
ols, a subfamily of flavonoid polyphenolic compounds that
are abundant in grape seeds and peels, green tea, nuts, and
berries. Epicatechins, such as (-)-epicatechin gallate, inhibit
the expression of virulence genes associated with secretion
of proteins in Staphylococcus aureus (Shah et al., 2008). To
the best of our knowledge, few reports have characterized
epicatechins isolated from the leaves of plants of the Annonaceae
family, and even fewer reports have been published on their
antibacterial actions (Lage et al., 2014). Fisetin (3,3′,4′,7-
tetrahydroxyflavone), another biologically active flavonoid, was
also identified in SF32-33. Although this compound does
not present antimicrobial properties, it has been suggested
as a possible anti-virulence approach. Indeed, fisetin inhibits
the action of listeriolysin O, a hemolytic toxin produced by
Listeria monocytogenes whose main function is to facilitate
bacterial replication and evasion from the host immune system
(Wang et al., 2015). Another compound identified in SF32-
33 is quercetin (3,3′,4′,5,7-pentahydroxyflavone). Reports have
shown a potential use for this compound when combined
with either epigallocatechin-3-gallate c, against drug-resistant
Mycobacterium tuberculosis (Dey et al., 2015), or oxacillin,
causing damage in the cell walls of multi-resistant Staphylococcus
aureus (Amin et al., 2015). It is possible that all the
compounds identified herein act synergistically, contributing to
the antimicrobial effects of SF32-33.
We next assessed the ability of SF32-33 to interact with the cell
wall of P. aeruginosa. We found that incubation of SF32-33 with
P. aeruginosa caused a shift in the ZP from a negative to positive
charge. We suggest that this interaction is mediated by the
flavonoids present in the SF32-33. In fact, flavonoids have been
reported to interact with E. coli cell wall proteins, changing their
structure, and this has been associated with an increase in ZP (Wu
et al., 2013). We additionally performed ITC assays and found
that the incubation of SF32-33 with P. aeruginosa promotes an
endothermic reaction. We suggest that this entropic reaction is
a result of the hydrophobic interactions between flavonoids in
the SF32-33 and the bacterial cell wall surface, leading to a high
extension of desolvation of ions and water molecules. These data
taken together suggest that the interactions between SF32-33 and
the P. aeruginosa cell wall account for the antibacterial actions of
this A. glabra SF.
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Collectively, our results show that flavonoids obtained from
the EAF of A. glabra are effective against P. aeruginosa due to
their ability to interact with the bacterial cell wall, and thus, may
represent an alternative treatment for P. aeruginosa infection.
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